Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs FCEL✓SelectedUSD · FCELMRNA vs FCEL performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs FCEL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+305.2%
FCEL return
-61.5%
Excess return
+366.7%
Maximum drawdown
-34.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioFCELExcessAlpha
1D-2.2%-11.9%+9.7%-0.9%
7D-12.7%-30.9%+18.2%-9.5%
30D-20.7%-49.3%+28.6%-15.8%
3M+46.3%-63.6%+109.8%+57.0%
6M+305.2%-66.9%+372.2%+312.8%
All+305.2%-61.5%+366.7%+312.8%

Cumulative growth

Daily Returns

Daily percentage return beside FCEL.

Daily Out/Under-Performance

Portfolio return minus FCEL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FCEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded FCEL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling